B-Cell	0	6	VEGFR1	VEGFR1	NN	B-NP
I-Cell	6	7	-	-	HYPH	I-NP
I-Cell	7	15	positive	positive	JJ	I-NP
I-Cell	16	30	haematopoietic	haematopoietic	JJ	I-NP
I-Cell	31	35	bone	bone	NN	I-NP
I-Cell	36	42	marrow	marrow	NN	I-NP
I-Cell	43	54	progenitors	progenitor	NNS	I-NP
O	55	63	initiate	initiate	VBP	B-VP
O	64	67	the	the	DT	B-NP
O	68	71	pre	pre	AFX	I-NP
O	71	72	-	-	HYPH	I-NP
O	72	82	metastatic	metastatic	JJ	I-NP
O	83	88	niche	niche	NN	I-NP
O	88	89	.	.	.	O

O	91	94	The	The	DT	B-NP
B-Cell	95	103	cellular	cellular	JJ	I-NP
O	104	107	and	and	CC	I-NP
O	108	117	molecular	molecular	JJ	I-NP
O	118	128	mechanisms	mechanism	NNS	I-NP
O	129	131	by	by	IN	B-PP
O	132	137	which	which	WDT	B-NP
O	138	139	a	a	DT	B-NP
B-Cell	140	146	tumour	tumour	NN	I-NP
I-Cell	147	151	cell	cell	NN	I-NP
O	152	161	undergoes	undergo	VBZ	B-VP
O	162	172	metastasis	metastasis	NN	B-NP
O	173	175	to	to	TO	B-PP
O	176	177	a	a	DT	B-NP
O	178	191	predetermined	predetermine	VBN	I-NP
O	192	200	location	location	NN	I-NP
O	201	204	are	be	VBP	B-VP
O	205	212	largely	largely	RB	B-ADJP
O	213	220	unknown	unknown	JJ	I-ADJP
O	220	221	.	.	.	O

O	222	226	Here	Here	RB	B-ADVP
O	227	229	we	we	PRP	B-NP
O	230	241	demonstrate	demonstrate	VBP	B-VP
O	242	246	that	that	IN	B-SBAR
B-Cell	247	251	bone	bone	NN	B-NP
I-Cell	252	258	marrow	marrow	NN	I-NP
I-Cell	258	259	-	-	HYPH	B-VP
I-Cell	259	266	derived	derive	VBN	B-NP
I-Cell	267	281	haematopoietic	haematopoietic	JJ	I-NP
I-Cell	282	292	progenitor	progenitor	NN	I-NP
I-Cell	293	298	cells	cell	NNS	I-NP
O	299	303	that	that	WDT	B-NP
O	304	311	express	express	VBP	B-VP
O	312	320	vascular	vascular	JJ	B-NP
O	321	332	endothelial	endothelial	JJ	I-NP
O	333	339	growth	growth	NN	I-NP
O	340	346	factor	factor	NN	I-NP
O	347	355	receptor	receptor	NN	I-NP
O	356	357	1	1	CD	I-NP
O	358	359	(	(	(	O
O	359	365	VEGFR1	VEGFR1	NN	B-NP
O	365	366	;	;	:	O
O	367	371	also	also	RB	B-VP
O	372	377	known	know	VBN	I-VP
O	378	380	as	as	IN	B-PP
O	381	385	Flt1	Flt1	NN	B-NP
O	385	386	)	)	)	O
O	387	391	home	home	NN	B-ADVP
O	392	394	to	to	TO	B-PP
B-Cancer	395	401	tumour	tumour	NN	B-NP
O	401	402	-	-	HYPH	O
O	402	410	specific	specific	JJ	B-NP
B-Multi-tissue_structure	411	414	pre	pre	AFX	I-NP
I-Multi-tissue_structure	414	415	-	-	HYPH	I-NP
I-Multi-tissue_structure	415	425	metastatic	metastatic	JJ	I-NP
I-Multi-tissue_structure	426	431	sites	site	NNS	I-NP
O	432	435	and	and	CC	O
O	436	440	form	form	VB	B-VP
B-Cell	441	449	cellular	cellular	JJ	B-NP
I-Cell	450	458	clusters	cluster	NNS	I-NP
O	459	465	before	before	IN	B-PP
O	466	469	the	the	DT	B-NP
O	470	477	arrival	arrival	NN	I-NP
O	478	480	of	of	IN	B-PP
B-Cell	481	487	tumour	tumour	NN	B-NP
I-Cell	488	493	cells	cell	NNS	I-NP
O	493	494	.	.	.	O

O	495	505	Preventing	Prevent	VBG	B-VP
O	506	512	VEGFR1	VEGFR1	NN	B-NP
O	513	521	function	function	NN	I-NP
O	522	527	using	use	VBG	B-VP
O	528	538	antibodies	antibody	NNS	B-NP
O	539	541	or	or	CC	B-PP
O	542	544	by	by	IN	B-PP
O	545	548	the	the	DT	B-NP
O	549	556	removal	removal	NN	I-NP
O	557	559	of	of	IN	B-PP
B-Cell	560	566	VEGFR1	VEGFR1	NN	B-NP
I-Cell	566	567	(	(	(	O
I-Cell	567	568	+	+	SYM	O
I-Cell	568	569	)	)	)	O
I-Cell	570	575	cells	cell	NNS	B-NP
O	576	580	from	from	IN	B-PP
O	581	584	the	the	DT	B-NP
B-Multi-tissue_structure	585	589	bone	bone	NN	I-NP
I-Multi-tissue_structure	590	596	marrow	marrow	NN	I-NP
O	597	599	of	of	IN	B-PP
O	600	604	wild	wild	JJ	B-NP
O	604	605	-	-	HYPH	I-NP
O	605	609	type	type	NN	I-NP
O	610	614	mice	mouse	NNS	I-NP
O	615	624	abrogates	abrogate	VBZ	B-VP
O	625	628	the	the	DT	B-NP
O	629	638	formation	formation	NN	I-NP
O	639	641	of	of	IN	B-PP
O	642	647	these	these	DT	B-NP
B-Cell	648	651	pre	pre	AFX	I-NP
I-Cell	651	652	-	-	HYPH	I-NP
I-Cell	652	662	metastatic	metastatic	JJ	I-NP
I-Cell	663	671	clusters	cluster	NNS	I-NP
O	672	675	and	and	CC	O
O	676	684	prevents	prevent	VBZ	B-VP
B-Cancer	685	691	tumour	tumour	NN	B-NP
O	692	702	metastasis	metastasis	NN	I-NP
O	702	703	,	,	,	O
O	704	711	whereas	whereas	IN	O
O	712	726	reconstitution	reconstitution	NN	B-NP
O	727	731	with	with	IN	B-PP
O	732	740	selected	select	VBN	B-NP
O	741	744	Id3	Id3	NN	I-NP
O	745	746	(	(	(	O
O	746	755	inhibitor	inhibitor	NN	B-NP
O	756	758	of	of	IN	B-PP
O	759	774	differentiation	differentiation	NN	B-NP
O	775	776	3	3	CD	I-NP
O	776	777	)	)	)	O
O	777	778	-	-	HYPH	B-NP
O	778	787	competent	competent	JJ	I-NP
B-Cell	788	794	VEGFR1	VEGFR1	NN	I-NP
I-Cell	794	795	+	+	SYM	B-NP
I-Cell	796	801	cells	cell	NNS	I-NP
O	802	813	establishes	establish	VBZ	B-VP
B-Cell	814	821	cluster	cluster	NN	B-NP
O	822	831	formation	formation	NN	I-NP
O	832	835	and	and	CC	O
B-Cancer	836	842	tumour	tumour	NN	B-NP
O	843	853	metastasis	metastasis	NN	I-NP
O	854	856	in	in	IN	B-PP
O	857	860	Id3	Id3	NN	B-NP
O	861	869	knockout	knockout	NN	I-NP
O	870	874	mice	mouse	NNS	I-NP
O	874	875	.	.	.	O

O	876	878	We	We	PRP	B-NP
O	879	883	also	also	RB	B-ADVP
O	884	888	show	show	VBP	B-VP
O	889	893	that	that	IN	B-SBAR
B-Cell	894	900	VEGFR1	VEGFR1	NN	B-NP
I-Cell	900	901	+	+	SYM	B-NP
I-Cell	902	907	cells	cell	NNS	I-NP
O	908	915	express	express	VBP	B-VP
O	916	919	VLA	VLA	NN	B-NP
O	919	920	-	-	HYPH	B-NP
O	920	921	4	4	CD	I-NP
O	922	923	(	(	(	O
O	923	927	also	also	RB	B-VP
O	928	933	known	know	VBN	I-VP
O	934	936	as	as	IN	B-PP
O	937	945	integrin	integrin	NN	B-NP
O	946	957	alpha4beta1	alpha4beta1	NN	I-NP
O	957	958	)	)	)	O
O	958	959	,	,	,	O
O	960	963	and	and	CC	O
O	964	968	that	that	IN	B-SBAR
B-Cancer	969	975	tumour	tumour	NN	B-NP
O	975	976	-	-	HYPH	B-NP
O	976	984	specific	specific	JJ	I-NP
O	985	991	growth	growth	NN	I-NP
O	992	999	factors	factor	NNS	I-NP
O	1000	1010	upregulate	upregulate	VBP	B-VP
O	1011	1022	fibronectin	fibronectin	NN	B-NP
O	1022	1023	-	-	HYPH	B-ADJP
O	1023	1024	-	-	:	O
O	1024	1025	a	a	DT	B-NP
O	1026	1029	VLA	VLA	NN	I-NP
O	1029	1030	-	-	HYPH	O
O	1030	1031	4	4	CD	B-NP
O	1032	1038	ligand	ligand	NN	I-NP
O	1038	1039	-	-	HYPH	O
O	1039	1040	-	-	HYPH	B-NP
O	1040	1042	in	in	IN	B-PP
O	1043	1051	resident	resident	JJ	B-NP
B-Cell	1052	1063	fibroblasts	fibroblast	NNS	I-NP
O	1063	1064	,	,	,	O
O	1065	1074	providing	provide	VBG	B-VP
O	1075	1076	a	a	DT	B-NP
O	1077	1087	permissive	permissive	JJ	I-NP
O	1088	1093	niche	niche	NN	I-NP
O	1094	1097	for	for	IN	B-PP
O	1098	1106	incoming	income	VBG	B-VP
B-Cell	1107	1113	tumour	tumour	NN	B-NP
I-Cell	1114	1119	cells	cell	NNS	I-NP
O	1119	1120	.	.	.	O

O	1121	1132	Conditioned	Condition	VBN	B-NP
O	1133	1138	media	medium	NNS	I-NP
O	1139	1147	obtained	obtain	VBN	B-VP
O	1148	1152	from	from	IN	B-PP
O	1153	1161	distinct	distinct	JJ	B-NP
B-Cancer	1162	1168	tumour	tumour	NN	I-NP
O	1169	1174	types	type	NNS	I-NP
O	1175	1179	with	with	IN	B-PP
O	1180	1186	unique	unique	JJ	B-NP
O	1187	1195	patterns	pattern	NNS	I-NP
O	1196	1198	of	of	IN	B-PP
O	1199	1209	metastatic	metastatic	JJ	B-NP
O	1210	1216	spread	spread	NN	I-NP
O	1217	1227	redirected	redirect	VBD	B-VP
O	1228	1239	fibronectin	fibronectin	NN	B-NP
O	1240	1250	expression	expression	NN	I-NP
O	1251	1254	and	and	CC	O
B-Cell	1255	1262	cluster	cluster	NN	B-NP
O	1263	1272	formation	formation	NN	I-NP
O	1272	1273	,	,	,	O
O	1274	1281	thereby	thereby	RB	B-VP
O	1282	1294	transforming	transform	VBG	I-VP
O	1295	1298	the	the	DT	B-NP
O	1299	1309	metastatic	metastatic	JJ	I-NP
O	1310	1317	profile	profile	NN	I-NP
O	1317	1318	.	.	.	O

O	1319	1324	These	These	DT	B-NP
O	1325	1333	findings	finding	NNS	I-NP
O	1334	1345	demonstrate	demonstrate	VBP	B-VP
O	1346	1347	a	a	DT	B-NP
O	1348	1359	requirement	requirement	NN	I-NP
O	1360	1363	for	for	IN	B-PP
B-Cell	1364	1370	VEGFR1	VEGFR1	NN	B-NP
I-Cell	1370	1371	+	+	CC	O
I-Cell	1372	1386	haematopoietic	haematopoietic	JJ	B-NP
I-Cell	1387	1398	progenitors	progenitor	NNS	I-NP
O	1399	1401	in	in	IN	B-PP
O	1402	1405	the	the	DT	B-NP
O	1406	1416	regulation	regulation	NN	I-NP
O	1417	1419	of	of	IN	B-PP
O	1420	1430	metastasis	metastasis	NN	B-NP
O	1430	1431	,	,	,	O
O	1432	1435	and	and	CC	O
O	1436	1443	suggest	suggest	VBP	B-VP
O	1444	1448	that	that	IN	B-SBAR
O	1449	1459	expression	expression	NN	B-NP
O	1460	1468	patterns	pattern	NNS	I-NP
O	1469	1471	of	of	IN	B-PP
O	1472	1483	fibronectin	fibronectin	NN	B-NP
O	1484	1487	and	and	CC	I-NP
B-Cell	1488	1494	VEGFR1	VEGFR1	NN	I-NP
I-Cell	1494	1495	+	+	SYM	B-NP
I-Cell	1495	1498	VLA	VLA	NN	I-NP
I-Cell	1498	1499	-	-	HYPH	B-NP
I-Cell	1499	1500	4	4	CD	I-NP
I-Cell	1500	1501	+	+	SYM	I-NP
I-Cell	1502	1510	clusters	cluster	NNS	I-NP
O	1511	1518	dictate	dictate	VBP	B-VP
B-Organ	1519	1524	organ	organ	NN	B-NP
O	1524	1525	-	-	HYPH	B-NP
O	1525	1533	specific	specific	JJ	I-NP
B-Cancer	1534	1540	tumour	tumour	NN	I-NP
O	1541	1547	spread	spread	NN	I-NP
O	1547	1548	.	.	.	O

